Metastatic Malignant Solid Neoplasm Clinical Trials in Mineola, New York

3 studies are recruiting for metastatic malignant solid neoplasm in Mineola, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

    This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) …

    Stage
    Phase 2
    Ages
    Any age
    Site
    NYU Langone Hospital - Long Island, Mineola, New York
    Locations
    482 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT05564377 on ClinicalTrials.gov

  2. Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors

    This phase I trial tests the safety, side effects and best dose of peposertib (M3814) in combination with tuvusertib (M1774) in treating patients with solid tumors that have spread to other places in the body (advanced). Peposertib and tuvusertib stop the growth of tumor cells by blocking some of t…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    NYU Langone Hospital - Long Island, Mineola, New York
    Locations
    7 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT05687136 on ClinicalTrials.gov

  3. Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

    This phase I trial tests the safety, side effects, and best dose of novobiocin in treating cancer patients with alterations in deoxyribonucleic acid (DNA) repair genes. Novobiocin is an antibiotic that blocks the activity of a protein called DNA polymerase theta, which helps repair DNA that has bec…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    NYU Langone Hospital - Long Island, Mineola, New York
    Locations
    23 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT05687110 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.